Related Experiment Video
Updated: Aug 20, 2026

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
Protective role of melatonin in ochratoxin a toxicity in rat heart and lung
Huseyin Okutan1, Gulsen Aydin, Nurten Ozcelik
1Süleyman Demirel University, School of Medicine, Department of Cardiovascular Surgery, Isparta, Turkey. okutanh@yahoo.com
Abstract:
Ochratoxin A (OTA) is a mycotoxin produced by different fungi. The most pronounced adverse effect of OTA is hepatonephrotoxicity. Melatonin (MEL) has an antioxidant effect and has free-radical scavenger properties. The effects of OTA on heart and lung tissue and possible ameliorating effects of MEL were investigated in rats. Twenty-four rats were allocated to three groups (each with eight rats): control; OTA-treated group (OTA dose 289 microg kg(-1) per day); and OTA + MEL-treated group (MEL dose 10 mg kg(-1) per day). After 30 days of treatment, the histopathological changes in the heart and lung of all groups were examined. Compared with the control rats, myocardial tissue of rats treated with OTA showed extensive cytoplasmic vacuole formation, necrosis of the myocytes, dissolution of the nucleus, clumped fibres, fibrillolysis, swollen myocardial fibres, small haemorrhagic areas and hyperaemic vessels (P <0.05). In addition, lungs of rats treated with OTA showed alveolar congestion, alveolar cell hyperplasia, prominent alveolar septal vessels, variable intensity loss of alveolar architecture, intraparenchymal inflammatory infiltration, intraparenchymal hyperaemic vessels, respiratory epithelial proliferation, perivascular and peribronchial inflammation, pneumonic infiltration, distorted appearance of lung parenchyma and emphysematous areas (P <0.05). In comparison with the OTA groups, the ameliorating effects of MEL in the lung damage parameters were on alveolar cell hyperplasia, prominent alveolar septal vessels, variable intensity loss of alveolar architecture, intraparenchymal inflammatory infiltration, perivascular inflammatory inflammation, distorted appearance of lung parenchyma and focal emphysematous areas in lung (P <0.05). Melatonin also significantly reduced myocardial damage in most of the parameters: extensive cytoplasmic vacuole formation, necrosis of the myocytes, clumped fibres, fibrillolysis, small haemorrhagic areas and hypaeremic vessels in heart (P <0.05). On the other hand, MEL did not lower the degree of damage in lung and heart to the level of the control rats, except for the parameters of the interstitial oedema and small haemorrhagic areas only in myocardial tissue. Histopathological findings showed that OTA induced damage in heart and lung and MEL treatment significantly reduced the degree of damage.
Insights
Ochratoxin A (OTA) causes significant heart and lung damage in rats. Melatonin (MEL) treatment demonstrated protective effects, reducing OTA-induced toxicity in these organs.
Area of Science:
- Toxicology
- Pathology
- Pharmacology
Background:
- Ochratoxin A (OTA) is a fungal mycotoxin known for its hepatonephrotoxic effects.
- Melatonin (MEL) possesses antioxidant and free-radical scavenging properties.
Purpose of the Study:
- To investigate the histopathological effects of OTA on rat heart and lung tissues.
- To evaluate the potential ameliorating effects of MEL against OTA-induced cardiotoxicity and pulmonary toxicity.
Main Methods:
- Rats were divided into three groups: control, OTA-treated, and OTA + MEL-treated.
- Histopathological examination of heart and lung tissues was performed after 30 days of treatment.
- Specific dosages: OTA (289 μg/kg/day), MEL (10 mg/kg/day).
Main Results:
- OTA induced significant myocardial damage, including cytoplasmic vacuolization, myocyte necrosis, and vascular changes.
- OTA exposure led to substantial lung damage, characterized by alveolar congestion, hyperplasia, inflammation, and architectural distortion.
- MEL treatment significantly reduced most OTA-induced histopathological damage in both heart and lung tissues, though not to control levels.
Conclusions:
- Ochratoxin A induces significant histopathological damage in rat cardiac and pulmonary tissues.
- Melatonin exhibits a significant protective effect against OTA-induced cardiotoxicity and pulmonary toxicity.
- Further research may explore MEL as a potential therapeutic agent against mycotoxin-induced organ damage.
